Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:16
  • preuzimanja u poslednjih 30 dana:6

Sadržaj

članak: 2 od 82  
Back povratak na rezultate
2020, vol. 49, br. 3, str. 75-88
Značaj brze dijagnostike SARS-CoV-2, dobre zdravstvene organizacije i razumnog korišćenja znanja i resursa tokom borbe protiv Kovid-19
aOpšta bolnica Jesenice, Jesenice, Slovenija
bUniverzitet u Beogradu, Medicinski fakultet, Institut za mikrobiologiju i imunologiju

e-adresamihaskvarc@hotmail.com
Sažetak
U decembru 2019. godine pojavila se nova bolest, upala pluća nepoznatog uzroka, povezana sa pijacom morskih plodova u mestu Vuhan (Kina). Na humanim epitelnim ćelijama respiratornog trakta je izolovan jedan Nov koronavirus, nazvan prema kliničkoj slici "teški akutni respiratorni sindrom korona virus 2" (SARS-CoV-2), dok je bolest nazvana koronavirusna bolest 2019 (Kovid-19). Pokazalo se da je ova pandemija veliki izazov, kako za stručnjake koji se bave mikrobiološkom dijagnostikom, tako i za sve zdravstvene radnike. Cilj ovog rada je da prikaže značaj brze dijagnostike SARS-CoV-2, značaj zaštite zdravlja zdravstvenih radnika i razumnog korišćenja znanja i resursa tokom borbe protiv Kovid-19. Dosadašnja istraživanja potvrđuju da su u borbi protiv SARS-CoV-2 infekcije od posebnog značaja brza dijagnostika SARS-CoV-2, zaštita zdravlja zdravstvenih radnika i razumno korišćenje znanja i resursa tokom pandemije. Poseban akcenat se stavlja na sprovođenje vakcinisanja protiv sezonskog gripa, kao i protiv invazivne pneumokokne bolesti, jer primenom ovih vakcina možemo olakšati postavljanje dijagnoze Kovid-19 u budućem period u kome se sa velikim nadama očekuje efikasna antivirusna terapija za SARS-CoV-2 i vakcina za Kovid-19.
Reference
Alhazzani, W., Møller, M.H., Arabi, Y.M., Loeb, M., Ng, G.M., Fan, E., Oczkowski, S., Levy, M.M., Derde, L., Dzierba, A., Du, B., Aboodi, M., Wunsch, H., Cecconi, M., Koh, Y., Chertow, D.S. (2020) Surviving Sepsis Campaign: Guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med, 46: 854-87
Burton, A., Burgess, C., Dean, S., Koutsopoulou, G.Z., Hugh-Jones, S. (2017) How effective are mindfulness-based interventions for reducing stress among healthcare professionals?: A systematic review and meta-analysis. Stress and Health, 33(1): 3-13
Dong, E., Du, H., Gardner, L. (2020) An interactive Web-based dashboard to track COVID-19 in real time. Lancet Infectious Diseases, 20(5): P533-534
ECDC Novel coronavirus (SARS-CoV-2): Discharge criteria for confirmed COVID-19 cases. https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-Discharge-criteria.pdf [pristupljeno 03.04.2020]
Emanuel, E.J., Persad, G., Upshur, R., Thome, B., Parker, M., Glickman, A., Zhang, C., Boyle, C., Smith, M., Phillips, J.P. (2020) Fair allocation of scarce medical resources in the time of Covid-19. New England Journal of Medicine, 382(21): 2049-2055
European Centre for Disease Prevention and Control -An agency of the European Union Diagnostic testing and screening for SARS-CoV-2. https://www.ecdc.europa.eu/en/covid-19/latest-evidence/diagnostic-testing [Pristupljeno 03.04.2020.]
FDA Emergency use authorization: EUAs. In vitro diagnostics, https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations#covid19ivd [pristupljeno 03.04.2020]
Guan, W., Liang, W., Zhao, Y., Liang,, Chen, Z., Li, Y., i dr. (2020) Comorbidity and its impact on 1590 patients with Covid-19 in China: A nationwide analysis. Eur Respir J, 55(5):2000547
Hall, L.H., Johnson, J., Watt, I., Tsipa, A., O'Connor, D.B. (2016) Healthcare staff wellbeing, burnout, and patient safety: A systematic review. PLoS One, 11(7):e0159015
Haveri, A., Smura, T., Kuivanen, S., Österlund, P., Hepojoki, J., Ikonen, N., Pitkäpaasi, M., Blomqvist, S., Rönkkö, E., Kantele, A., Strandin, T., Kallio-Kokko, H., Mannonen, L., Lappalainen, M., Broas, M., Jiang, M. (2020) Serological and molecular findings during SARS-CoV-2 infection: The first case study in Finland: January to February 2020. Eurosurveillance, 25(11): pii=2000266
Khan, S., Siddique, R., Shereen, M.A., Ali, A., Liu, J., Bai, Q., i dr. (2020) The emergence of a novel coronavirus (SARSCoV-2), their biology and therapeutic options. J Clin Microbiol, 58(5):e00187-20
Koo, J.R., Cook, A.R., Park, M., Sun, Y., Sun, H., Lim, J.T., Tam, C., Dickens, B.L. (2020) Interventions to mitigate early spread of SARS-CoV-2 in Singapore: A modelling study. Lancet Infectious Diseases, 20(6): P678-688
Krause, P.J., Gross, P.A., Barrett, T.L., Dellinger, E.P., Martone, W.J., McGowan, J.E. J., i dr., the Infectious Diseases Society of America (1994) Quality standard for assurance of measles immunity among health care workers. Infect Control Hosp Epidemiol, 15(3):193-9
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., Li, S., He, J. (2020) Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncology, 21(3): 335-337
Loeffelholz, M.J., Tang, Y. (2020) Laboratory diagnosis of emerging human coronavirus infections: The state of the art. Emerging Microbes & Infections, 9(1): 747-756
Moriyama, M., Hugentobler, W.J., Iwasaki, A. (2020) Seasonality of respiratory viral infections. Annual Review of Virology, 7(1): 83-101
Nalla, A.K., Casto, A.M., Huang, M.W.W., Perchetti, G.A., Sampoleo, R., Shrestha, L., Wei, Y., Zhu, H., Jerome, K.R., Greninger, A.L. (2020) Comparative performance of SARS-CoV-2 detection assays using seven different primer-probe sets and one assay kit. Journal of Clinical Microbiology, 58(6):e00557-20
NHS England (2020) Clinical guide for the management of noncoronavirus patients requiring acute treatment: Cancer. 23 March, version 2, https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/specialty-guide-acute-treatment-cancer-23-march-2020.pdf [pristupljeno 03.04]
Nickel, C.H., Bingisser, R. (2020) Mimics and chameleons of COVID-19. Swiss Medical Weekly, 150:w20231
Remuzzi, A., Remuzzi, G. (2020) COVID-19 and Italy: What next?. Lancet, 395(10231): P1225-1228
The International Committee on Taxonomy of Viruses, Coronaviridae Study Group (2020) The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol, 5(4):536-544
van Doremalen, N., Bushmaker, T., Morris, D.H., Holbrook, M.G., Gamble, A., Williamson, B.N., Tamin, A., Harcourt, J.L., Thornburg, N.J., Gerber, S.I., Lloyd-Smith, J.O., de Wit, E., Munster, V.J. (2020) Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, 382(16): 1564-1567
WHO Situation reports. Coronavirus disease 2019 (COVID-19), https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports [Pristupljeno 03.04.2020.]
Wölfel, R., Corman, V.M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M.A., Niemeyer, D., Jones, T.C., Vollmar, P., Rothe, C., Hoelscher, M., Bleicker, T., Brünink, S., Schneider, J., Ehmann, R. (2020) Virological assessment of hospitalized patients with COVID-2019. Nature, 581(7809): 465-469
Yu, J., Ouyang, W., Chua, M.L.K., Xie, C. (2020) SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncology, 6(7): 1108-1110
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., Cao, B. (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet, 395(10229): 1054-1062; pii: S0140-6736(20)30566-3
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G.F., Tan, W. (2020) A Novel Coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, 382(8): 727-733
 

O članku

jezik rada: srpski, engleski
vrsta rada: aktuelni problemi
DOI: 10.5937/zdravzast49-28451
primljen: 17.09.2020.
revidiran: 03.10.2020.
prihvaćen: 08.10.2020.
objavljen onlajn: 09.10.2020.
objavljen u SCIndeksu: 24.10.2020.

Povezani članci

Stomatološki glasnik Srbije (2020)
Novi pristup efikasnoj zaštiti protiv kovida 19 baziran na nanotehnologiji
Jokanović Vukoman, i dr.

J Med Biochemistry (2021)
Značaj biohemijskih markera za praćenje COVID-19 pacijenata
Letelier Pablo, i dr.

Hrana i ishrana (2020)
COVID-19 kao prekretnica za upotrebu novih vrsta vakcina
Marković Milan

prikaži sve [15]